Christine Bryant

Christine Bryant currently serves as the Sr. Director of Clinical and Translational Science at Glyscend Therapeutics, providing scientific input to support research and development programs since April 2022. Previously, Christine held positions at Biosplice Therapeutics, including Director of Clinical and Translational Science and Sr. Director of Medical Writing, overseeing medical writing teams and regulatory documentation. Earlier experience includes roles at Vivo, Clarient, UC Irvine, Dana-Farber Cancer Institute, and Brigham and Women's Hospital, focusing on medical writing, scientific communication, and research in virology and cancer. Christine earned a Ph.D. in Virology from Harvard University and a B.S. in Biochemistry and Molecular Biology from UC Irvine.